BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30059533)

  • 1. Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population.
    Wang RY; Chen HJ; Huang CL; Wang JY; Lee TE; Lee HY; Hung CC
    PLoS One; 2018; 13(7):e0201408. PubMed ID: 30059533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision therapeutic opioid dosing implications from genetic biomarkers and craving score.
    Chang HW; Ho WC; Huang CL; Wang RY
    Medicine (Baltimore); 2020 May; 99(22):e20429. PubMed ID: 32481444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life for drug abusers accepting methadone maintenance treatment].
    Li XL; Tan HZ; Sun ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):601-5. PubMed ID: 18667773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment.
    Winklbaur B; Jagsch R; Ebner N; Thau K; Fischer G
    Eur Addict Res; 2008; 14(2):99-105. PubMed ID: 18334820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals.
    De Maeyer J; Vanderplasschen W; Camfield L; Vanheule S; Sabbe B; Broekaert E
    Int J Nurs Stud; 2011 Oct; 48(10):1244-57. PubMed ID: 21481390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.
    Zielinski L; Bhatt M; Sanger N; Plater C; Worster A; Varenbut M; Daiter J; Pare G; Marsh DC; Desai D; MacKillop J; Steiner M; McDermid Vaz S; Thabane L; Samaan Z
    Biol Sex Differ; 2017; 8():8. PubMed ID: 28367308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Randesi M; Shu X; Ott J; Shen PH; Adelson M; Kreek MJ
    Pharmacogenomics; 2013 May; 14(7):755-68. PubMed ID: 23651024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life.
    He Q; Wang X; Xia Y; Mandel JS; Chen A; Zhao L; Han L; Ling L
    Subst Use Misuse; 2011; 46(6):749-57. PubMed ID: 21114401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients on methadone maintenance treatment: a three-month assessment.
    Lashkaripour K; Bakhshani NM; Sadjadi SA
    J Pak Med Assoc; 2012 Oct; 62(10):1003-7. PubMed ID: 23866434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
    Liu CC; Fang CP; Liu TH; Kuo HW; Liu SC; Wang SC; Chen ACH; Liu YL
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():92-98. PubMed ID: 29330135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.